Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MedPAC's Permanent "Doc Fix" For Medicare Seeks $75 Bil. Offset From Drug Firms

This article was originally published in The Pink Sheet Daily

Executive Summary

The Medicare Payment Advisory Commission's draft plan seeks approximately $235 billion in offsets from a range of non-physician sources.

You may also be interested in...



Part D Rebates Linger As Possible Cost Offset Option In MedPAC's Medicare "Doc Fix"

Recommendation for physician sustainable growth rate repeal, including list of possible cost offsets, will be sent to Congress later this month.

Part D Rebates Linger As Possible Cost Offset Option In MedPAC's Medicare "Doc Fix"

Recommendation for physician sustainable growth rate repeal, including list of possible cost offsets, will be sent to Congress later this month.

Cost-Sharing Incentives Would Drive Higher Generic Drug Use By Low-Income Enrollees In Part D - MedPAC

Staff analysis found beneficiaries receiving subsidies have high brand use in categories where generics are available, including antipsychotics, diabetes, peptic ulcer treatment, cholesterol therapy.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS072780

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel